Sensex Finishes Marginally Lower; TCS Gains 0.9%

Tue, 17 Jan Closing

   Previous Close   

   Pre-Open   

   09:30 am   

   11:30 am   

   01:30 pm   

The Indian share markets finished the day on flat note with negative bias amid mixed Asian cues. At the closing bell, the BSE Sensex closed lower by 53 points, whereas the NSE Nifty finished lower by 15 points. The S&P BSE Mid cap ended flat while the S&P BSE Small Cap finished up by 0.3%. Sectoral indices finished the day on a mixed note with metal, oil & gas stocks leading the losses while, FMCG, power & IT stocks led the pack of gainers.

Asian markets finished mixed as of the most recent closing prices. The Nikkei 225 lost 1.5% and the Hang Seng rose 0.54%. The Shanghai Composite gained 0.17%. European markets are trading in red. The FTSE 100 is lower by 0.33%, while France's CAC 40 is off 0.51%. Shares in Germany are down with the DAX at 11,471.54.

The rupee was trading at Rs 68.05 against the US$ in the afternoon session. Oil prices were trading at US$ 53.19 at the time of writing.

IT stocks ended the day up by 0.3% with HCL Infosys and Info Edge leading the gainers. According to an article in the Livemint, Tech Mahindra has opened a new facility in Dublin, Ireland to focus on emerging technologies such as Robotics and Automation, Business Analytics, Cloud Infrastructure and Digital Services.

The Centre, to be operational in the first quarter of calendar year 2017 will be central to Tech Mahindra's operations in the country and would focus on emerging technologies. The move is in line with an overall shift in focus by Indian IT service providers to newer technologies in a quest to survive in a fast-changing IT services world.

The move comes in the wake of Britain's preparations to exit the European Union. Once Britain exits, Ireland would be the only English-speaking country in the EU. The new CoE would employ around 150 engineers over the next three years and will help the company deliver technology services to clients in Ireland as well as Europe.

India Lags Far Behind in the Race for Machines

The chart above presents a comparison regarding installation of industrial robots. So while India is gloating over its edge over China when it comes to low-cost labour, in fact, India is lagging way behind compared to other developing economies.

Meanwhile, Tata Consultancy Services (TCS), has partnered with Aurus to enhance omnichannel payment solutions with OmniStore. The partnership is to deliver payment solutions for retailers using TCS OmniStore. The omnichannel payment solution facilitates transactions across channels and delivers unmatched convenience and security to both end consumers and retailers.

Through this partnership with Aurus, retailers using TCS OmniStore will be able to easily process multiple payments across channels.

India is an information technology powerhouse. In an extremely challenging global economy, western corporations are now expecting Indian IT firms to deliver a more compelling value proposition in terms of growth prospects. Going forward, whether the Indian IT firms are up to the task will be the key thing to watch out for.

TCS share price ended the day up by 0.9%.

Moving on to the news from stocks in pharma sector. As per an article in a leading financial daily, Cadila Healthcare, and its subsidiary Zydus Pharmaceuticals (USA) Inc., have finalized an agreement with Kowa Pharmaceuticals America, Inc. and Nissan Chemical Industries, to settle all outstanding patent litigation related to Livalo (pitavastatin calcium) tablets.

Reportedly, Kowa and Nissan have granted licence to market Zydus' generic version of Livalo, beginning on May 2, 2023, or earlier under certain circumstances. Livalo tablets are indicated as an adjunctive therapy to diet to reduce elevated total cholesterol.

Recently, Cadila had also settled all outstanding patent litigation related to Qudexy XR (topiramate) extended-release capsules with US-based Upsher-Smith Laboratories, Inc. Qudexy XR extended-release capsules are used to treat certain kind of seizures in adults.

Innovators in the pharmaceutical industry largely make use of patents. They make heavy use of patents whenever they create a new drug. In one of our recent editions of The Equitymaster Digest, we wrote everything you need to know about patented drugs, its advantages and its implications. Here's a snippet:

• "That's how the innovators in the pharmaceutical industry work. They make heavy use of patents whenever they create a new drug. The patent allows them to recoup the high capital expenditure that goes into the research and development (R&D) of new drugs. Companies that have a patent on a particular product are immune from competition for the duration of the patent."

Cadila Healthcare share price ended the day up by 0.2%.

For information on how to pick stocks that have the potential to deliver big returns, download our special report now!

Read the latest Market Commentary

Top Gainers TodayTop Gainers over 1-WeekTop Gainers over 1-MonthTop Gainers over 1-YearTop Gainers over 3-YrsTop Gainers over 5-YrsTop Losers TodayTop Losers over 1-WeekTop Losers over 1-MonthTop Losers over 1-YearTop Losers over 3-YrsTop Losers over 5-YrsOnly BuyersOnly SellersMost Active StocksMost Popular Stocks52 Week High Stocks52 Week Low Stocks

INDICESBSE (Rs 0 to 1)BSE (Rs 1 to 2)BSE (Rs 2 to 4)BSE (Rs 4 to 10)BSE (Rs 10 to 20)BSE (Above Rs 20)BSE - AllBSE-30BSE-100BSE-200BSE-500BSE AutoBSE BankexBSE Capital GoodsBSE Consumer DurablesBSE FMCGBSE HealthcareBSE ITBSE MetalBSE Oil & GasBSE PSUBSE TeckBSE RealtyBSE PowerBSE A GroupBSE B GroupBSE Mid-CapBSE Small-CapBSE Basic MaterialsBSE Consumer DiscretionaryBSE IndustrialsBSE UtilitiesBSE Sensex 50BSE Sensex Next 50BSE Bharat 22BSE 150 MidCapBSE 250 SmallCapBSE 250 LargeMidCapBSE 400 MidSmallCapBSE AllCapBSE LargeCapBSE SmallCap SelectBSE 100 LargeCap TMCBSE InfraBSE ManufacturingBSE CPSEBSE Private BankBSE Diversified FinancialsBSE MomentumBSE Low VolatilityBSE QualityBSE Enhanced ValueBSE Divident StabilityS&P BSE IPOBSE SMEIPOBSE 100 ESGBSE CarbonexBSE GreenexNSE (Rs 0 to 10)NSE (Rs 10 to 20)NSE (Above Rs 20)NSE - AllNSE-50NSE ITNSE Nifty Midcap 50NSE JR. NiftyNSE Bank NiftyNIFTY Next 50NIFTY 100NIFTY 200NIFTY 500NIFTY MidCap 100NIFTY SmallCap 250NIFTY SmallCap 50NIFTY SmallCap 100NIFTY LargeMidCap 250NIFTY MidSmallCap 400NIFTY AutoNIFTY Consumer DurablesNIFTY FinanceNIFTY FMCGNIFTY MediaNIFTY MetalNIFTY PharmaNIFTY Private BankNIFTY PSU BankNIFTY RealtyNIFTY Oil & GasNIFTY SME EmergeNIFTY CommoditiesNIFTY CPSENIFTY EnergyNIFTY India ConsumptionNIFTY InfraNIFTY MNCNIFTY PSENIFTY Serv SectorNIFTY100 Liquid 15NIFTY Midcap Liquid 15NIFTY Midcap 150 Quality 50NIFTY50 Equal WeightNIFTY100 Equal WeightNIFTY100 Low Volatility 30NIFTY100 Alpha 30NIFTY Alpha 50NIFTY Dividend Opportunities 50NIFTY High Beta 50NIFTY Low Volatility 50NIFTY200 Quality 30NIFTY 500 Value 50NIFTY 100 Quality 30SECTORSAgricultureAirlinesAluminiumAsset Management CompaniesAutomobilesAuto AncillariesBanks (Private)Banks (PSU)BankingCementChemicalsDefenceDiagnosticsDronesEngineeringElectric VehicleElectric Vehicle BatteryEnergy SourcesESGEthanolFertilizersFintechFMCGFoodGreen HydrogenHotelsInfrastructureInsuranceInvestment and FinanceInvITIT (Large)IT (Others)LogisticsMediaMetalMiningIndia's Big Tech StocksIndian PharmaMNC PharmaPSUPaintPaperPlasticPowerRating AgenciesReal EstateREITsRenewable EnergyRetailingSemiconductorShippingSteelSugarSupply ChainTelecomTextilesTravel Support Services

10 results 25 results 50 results 100 results All results

Indian Share Market Update: Top Gainers and Losers